The Defense Logistics Agency awarded a $35,280 firm fixed price delivery order to Amerisourcebergen Drug Corporation for 4 MG nasal spray naloxone hydrochloride. As part of DLA's stockpile of opioid overdose reversal medications, this order will provide 2,000 units of the nasal spray to address the ongoing public health emergency. Amerisourcebergen will deliver the products from its Conshohocken, Pennsylvania distribution center by September 14, 2023 under the Medical-Surgical Prime Vendor contract. No subcontractors or set-aside designations were specified. This award supports DLA's mission to provide medical supplies and equipment to the Department of Defense and other federal agencies.
Generated 12/22/23, 1:33 PM